Michele Aragona
Overview
Explore the profile of Michele Aragona including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
338
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nicoli F, Citro F, Battini L, Aragona M, De Gennaro G, Marchetti P, et al.
J Endocrinol Invest
. 2025 Jan;
PMID: 39883312
Purpose: Women with gestational diabetes (GDM) have increased risk of hypertensive disorders in pregnancy (HDP). However, knowledge remains limited for women with high-risk metabolic profiles, regardless of GDM diagnosis. This...
2.
Citro F, Bianchi C, Belcari T, Galleano F, Venturi C, Battini L, et al.
J Diabetes Sci Technol
. 2024 Oct;
:19322968241289957.
PMID: 39417492
Background: The Glycemia Risk Index (GRI) describes the quality of glycemic control, emphasizing extreme hypoglycemia and hyperglycemia more than less extreme values. However, a pregnancy-specific GRI (pGRI), tailored to the...
3.
Citro F, Bianchi C, Aragona M, Belcari T, Battini L, Marchetti P, et al.
Diabetes Res Clin Pract
. 2024 Mar;
210:111611.
PMID: 38479448
Aim: Continuous Glucose Monitoring (CGM) systems are not currently recommended to guide intrapartum glucose and insulin infusion, due to insufficient data. In this study, intrapartum accuracy of intermittently scanned CGM...
4.
Garofolo M, Lucchesi D, Giambalvo M, Aragona M, Bertolotto A, Campi F, et al.
Cardiovasc Diabetol
. 2024 Feb;
23(1):85.
PMID: 38419065
Background: Non-alcoholic fatty liver disease (NAFLD), identified by the Fatty Liver Index (FLI), is associated with increased mortality and cardiovascular (CV) outcomes. Whether this also applies to type 1 diabetes...
5.
Citro F, Bianchi C, Nicoli F, Aragona M, Marchetti P, Di Cianni G, et al.
Diabetes Res Clin Pract
. 2023 Oct;
205:110979.
PMID: 37890701
Aims: Over the recent years multiple therapeutic and management opportunities have been made available to treat pregnant women with Type 1 diabetes (T1DM). However, analyses assessing whether these different approaches...
6.
Citro F, Bertolotto A, Aragona M, Nicoli F, Bianchi C
Diabetes Technol Ther
. 2023 Apr;
25(8):574-575.
PMID: 37115528
No abstract available.
7.
Bianchi C, Brocchi A, Baronti W, Nicoli F, Citro F, Aragona M, et al.
Diabetes Metab Res Rev
. 2023 Feb;
39(5):e3625.
PMID: 36806857
Aims: To evaluate the impact of assisted reproductive technology (ART) on the risk of gestational diabetes mellitus (GDM) in single pregnancies. Materials And Methods: We retrospectively collected clinical and anthropometric...
8.
Mattioli D, Vinicola V, Aragona M, Montuori M, Tarantino U, Capuani S
Bone
. 2022 Aug;
164:116514.
PMID: 35952974
Aim: Identify new potential biomarkers of osteoporosis at an early stage, by magnetic resonance spectroscopy (MRS), studying early changes in the metabolic profile of bone-marrow fatty acids in women's calcanei...
9.
Dardano A, Aragona M, Daniele G, Miccoli R, Del Prato S
Front Endocrinol (Lausanne)
. 2022 Mar;
13:847778.
PMID: 35295985
Background: Type 2 diabetes (T2D) is a common comorbidity in people living with HIV (PLWH). Anti-hyperglycemic treatment in PLWH is still a challenge, and no randomized controlled studies using new...
10.
Falcetta P, Aragona M, Bertolotto A, Bianchi C, Campi F, Garofolo M, et al.
Metabolism
. 2021 Nov;
127:154941.
PMID: 34838778
The discovery of insulin in 1921 - due to the efforts of the Canadian research team based in Toronto - has been a landmark achievement in the history of medicine....